Inhibrx, Inc. (INBX) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17
	10-K	10-K	10-K	10-K	S-1/A	S-1/A
Revenues	2.2	7.2	12.9	13.2	33.5	25.5
Revenue growth	-69.7%	-43.9%	-2.4%	-60.5%	31.1%
Cost of goods sold	0.0	0.0	0.0	0.0	58.3	25.5
Gross profit	2.2	7.2	12.9	13.2	-24.9	0.0
Gross margin	100.0%	100.0%	100.0%	100.0%	-74.3%	0.0%
Selling, general and administrative [+]	21.1	12.4	6.8	6.3	4.7	2.6
General and administrative	21.1	12.4	6.8	6.3	4.7	2.6
Research and development	110.2	71.4	73.5	47.9
Equity in earnings			-0.5
Other operating expenses				2.8		17.1
EBITDA [+]	-127.9	-75.4	-66.9	-42.6	-28.8	-19.3
EBITDA growth	69.7%	12.6%	57.2%	47.6%	49.2%
EBITDA margin	-5834.5%	-1042.3%	-519.2%	-322.1%	-86.2%	-75.8%
Depreciation and amortization	1.2	1.2	1.0	1.2	0.7	0.4
EBIT [+]	-129.1	-76.6	-67.9	-43.7	-29.5	-19.7
EBIT growth	68.6%	12.7%	55.4%	48.1%	49.6%
EBIT margin	-5890.4%	-1058.8%	-527.1%	-330.9%	-88.2%	-77.3%
Interest expense	16.1	5.2	10.8	5.7
Interest expense	16.1	5.2	10.8	5.7
Other income (expense), net [+]	0.0	0.0	3.1	-1.1	-1.4	-2.1
Gain (loss) on derivative instruments			2.7	-1.0
Change in fair value of warrants			0.0
Other	0.0	0.0	0.0	-0.1	0.1
Pre-tax income	-145.2	-81.8	-75.6	-50.5	-30.9	-21.8
Income taxes	0.0	0.0	0.0	0.9	0.1	0.3
Minority interest					0.6	3.9
Net income	-145.2	-81.8	-76.1	-51.4	-31.0	-19.4
Net margin	-6625.3%	-1130.8%	-590.7%	-389.1%	-92.7%	-76.2%

Basic EPS [+]	($3.62)	($2.15)	($3.01)	($2.83)	($1.71)	($0.62)
Growth	68.3%	-28.6%	6.4%	65.7%	177.3%
Diluted EPS [+]	($3.62)	($2.15)	($3.01)	($2.83)	($1.71)	($0.62)
Growth	68.3%	-28.6%	6.4%	65.7%	177.3%

Shares outstanding (basic) [+]	40.1	38.0	25.3	18.2	18.2	31.6
Growth	5.5%	50.5%	39.1%	0.0%	-42.5%
Shares outstanding (diluted) [+]	40.1	38.0	25.3	18.2	18.2	31.6
Growth	5.5%	50.5%	39.1%	0.0%	-42.5%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.